Advances in Pediatric Medulloblastoma
(2024)
Advances in Pediatric Medulloblastoma: pp.
1-9.
Chapter 1
Subtyping of Group 3/4 medulloblastoma
as a potential prognostic biomarker
among patients treated with reduced dose
of craniospinal irradiation: a Japanese Pediatric
Molecular Neuro‑Oncology Group study